{
  "author": {
    "name": "Madeline Campbell",
    "webUrl": "/author/profile/madeline-campbell/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2023/05/19/sareptas-gene-therapy-gets-accelerated-approval-are-fda-fast-tracked-drugs-safe/",
        "title": "Sarepta's gene therapy gets FDA accelerated approval: Are fast-tracked drugs safe?",
        "byline": "Robert Langreth, Fiona Rutherford, Immanual John Milton and Madeline Campbell",
        "kicker": "Market Insights",
        "prettyDate": "May 19, 2023",
        "timeToRead": "9 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/09/Pharmaceutical-Lab-Article-202009151515.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/robert-langreth-fiona-rutherford-immanual-john-milton/",
            "name": "Robert Langreth, Fiona Rutherford, Immanual John Milton"
          },
          {
            "webUrl": "/author/profile/madeline-campbell/",
            "name": "Madeline Campbell"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "The recommendation is a huge win for the pharmaceutical company, likely paving the way for the company's first-of-its-kind gene therapy for treat Duchenne muscular dystrophy, a deadly disease.",
        "body": null
      }
    ]
  }
}